F. Scotté

434 total citations
18 papers, 298 citations indexed

About

F. Scotté is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, F. Scotté has authored 18 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in F. Scotté's work include Cancer Treatment and Pharmacology (4 papers), Prostate Cancer Treatment and Research (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). F. Scotté is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Prostate Cancer Treatment and Research (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). F. Scotté collaborates with scholars based in France, Luxembourg and Italy. F. Scotté's co-authors include Jean-Philippe Durand, Éric Raymond, Emmanuel Mitry, Y. Yataghene, G. Deplanque, Romain Coriat, Olivier Mir, François Goldwasser, Patrice Herait and J.M. Gornet and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

F. Scotté

13 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Scotté France 5 191 86 62 50 46 18 298
Y. Yataghene France 7 156 0.8× 118 1.4× 59 1.0× 33 0.7× 42 0.9× 15 290
Franziska Jahn Germany 13 180 0.9× 73 0.8× 82 1.3× 154 3.1× 23 0.5× 21 528
Noah Kolb United States 11 404 2.1× 107 1.2× 154 2.5× 70 1.4× 78 1.7× 26 555
Celia M. Bridges United States 13 373 2.0× 51 0.6× 171 2.8× 73 1.5× 128 2.8× 20 505
Keiichiro Imanaka Japan 10 28 0.1× 124 1.4× 95 1.5× 91 1.8× 36 0.8× 16 352
Gralla Rj United States 12 181 0.9× 123 1.4× 23 0.4× 29 0.6× 16 0.3× 29 389
James Gilmore United States 10 51 0.3× 42 0.5× 12 0.2× 113 2.3× 54 1.2× 30 361
Jeremey Levin United States 12 187 1.0× 69 0.8× 14 0.2× 67 1.3× 4 0.1× 23 357
M. González‐Barón Spain 9 213 1.1× 67 0.8× 9 0.1× 60 1.2× 14 0.3× 20 316
L. Geeraerts United States 7 162 0.8× 79 0.9× 7 0.1× 145 2.9× 9 0.2× 7 426

Countries citing papers authored by F. Scotté

Since Specialization
Citations

This map shows the geographic impact of F. Scotté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Scotté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Scotté more than expected).

Fields of papers citing papers by F. Scotté

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Scotté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Scotté. The network helps show where F. Scotté may publish in the future.

Co-authorship network of co-authors of F. Scotté

This figure shows the co-authorship network connecting the top 25 collaborators of F. Scotté. A scholar is included among the top collaborators of F. Scotté based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Scotté. F. Scotté is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mahé, Isabelle, Didier Mayeur, Françis Couturaud, et al.. (2024). Traduction et republication de : « Traitement anticoagulant de la maladie veineuse thromboembolique associée au cancer ». La Revue de Médecine Interne. 45(4). 210–225. 2 indexed citations
2.
3.
Bouillet, T., S. Dauchy, Corinne Delcambre, et al.. (2015). Role of physical activity and sport in oncology. Critical Reviews in Oncology/Hematology. 94(1). 74–86. 51 indexed citations
4.
Scotté, F., Kamel Laribi, Christian Gisselbrecht, et al.. (2015). 1040 Observational study for iron supplementation during Epoietin alpha biosimilar treatment of chemotherapy-induced anemia in cancer patients in oncology and haematology: The SYNERGY study. European Journal of Cancer. 51. S158–S159. 1 indexed citations
5.
Elaidi, Réza, F. Scotté, Elizabeth Fabre, et al.. (2014). Anemia As an Explanatory Factor for Fatigue in Patients Treated with Chemotherapy. Annals of Oncology. 25. iv527–iv527.
6.
Durand, Jean-Philippe, G. Deplanque, J.M. Gornet, et al.. (2011). Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Annals of Oncology. 23(1). 200–205. 144 indexed citations
7.
Bouillet, T., P. Calmels, S. Dauchy, et al.. (2011). Bénéfices sur la survie de l’activité physique avant ou après un cancer du sein. ONCOLOGIE. 13(12). 797–805. 2 indexed citations
8.
Bensadoun, René‐Jean, J. Durand, Mario Di Palma, F. Scotté, & Didier Mayeur. (2011). Prise en charge préventive et curative des mucites du tractus digestif (mucites buccopharyngées, œsogastro-intestinales et anorectales). ONCOLOGIE. 13(12). 825–832.
9.
Riquet, Marc, Patrick Bagan, Élizabeth Fabre-Guillevin, et al.. (2010). Adénopathies médiastinales malignes isolées. Revue de Pneumologie Clinique. 66(1). 36–40.
10.
Beuselinck, Benoit, Olivier Rixe, Stéphane Oudard, et al.. (2010). Site of metastasis in metastatic clear cell renal cell carcinoma (mccRCC) and outcome of treatment with sunitinib.. Journal of Clinical Oncology. 28(15_suppl). e15065–e15065. 2 indexed citations
11.
Riquet, Marc, Françoise Le Pimpec‐Barthes, F. Scotté, et al.. (2009). Intérêt de la chirurgie dans le cancer bronchique à petites cellules. Revue de Pneumologie Clinique. 65(3). 129–135. 3 indexed citations
12.
Durand, Jean-Philippe, Isabelle Madelaine, & F. Scotté. (2009). Recommandations pour la prévention et le traitement des nausées et vomissements induits par la chimiothérapie. Bulletin du Cancer. 96(10). 951–960. 25 indexed citations
13.
Durand, Jean-Philippe, G. Deplanque, Éric Raymond, et al.. (2009). Efficacy of venlafaxine for the prevention and relief of acute neurotoxicity of oxaliplatin: Results of EFFOX, a randomized, double-blinded, placebo-controlled prospective study. Journal of Clinical Oncology. 27(15_suppl). 9533–9533. 3 indexed citations
14.
Oudard, Stéphane, Eugéniu Banu, F. Scotté, et al.. (2007). Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients. Annals of Oncology. 18(11). 1828–1833. 51 indexed citations
15.
Scotté, F., Élizabeth Fabre-Guillevin, Antoine M. Dujon, & Marc Riquet. (2006). Retentissement opératoire des traitements néoadjuvants sur la chirurgie dans les cancers bronchiques non à petites cellules. Cancer/Radiothérapie. 11(1-2). 41–46. 3 indexed citations
16.
Oudard, Stéphane, Eugéniu Banu, F. Scotté, et al.. (2005). Docetaxel versus mitoxantrone as first-line chemotherapy for hormone-refractory prostate cancer (HRPC) patients. A meta-analysis of 3-year overall survival results. Journal of Clinical Oncology. 23(16_suppl). 4634–4634. 8 indexed citations
17.
Banu, Eugéniu, F. Scotté, Asima Banu, et al.. (2004). Corrected area under serum hemoglobin curve (Hb c-AUC) as a predictor of maximal hemoglobin response after erythropoietin (rHuEpo) treatment in chemotherapy induced anemia patients. Journal of Clinical Oncology. 22(14_suppl). 9586–9586. 3 indexed citations
18.
Oudard, Stéphane, Eugéniu Banu, Nicolas Thiounn, et al.. (2004). Corrected area under serum PSA curve as a predictor of survival after chemotherapy for hormone-refractory prostate cancer (HRPC) patients. Journal of Clinical Oncology. 22(14_suppl). 9579–9579.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y. Yataghene Breakdown of academic impact, for papers by Franziska Jahn Breakdown of academic impact, for papers by Noah Kolb Breakdown of academic impact, for papers by Celia M. Bridges Breakdown of academic impact, for papers by Keiichiro Imanaka Breakdown of academic impact, for papers by Gralla Rj Breakdown of academic impact, for papers by James Gilmore Breakdown of academic impact, for papers by Jeremey Levin Breakdown of academic impact, for papers by M. González‐Barón Breakdown of academic impact, for papers by L. Geeraerts
Rankless by CCL
2026